Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Molecular and Cellular Endocrinology|November 7, 2016
MicroRNAs in parathyroid physiopathologyV Vaira, C Verdelli, I Forno, et al.Journal of Endocrinological Investigation|January 12, 2015
MicroRNA deregulation in parathyroid tumours suggests an embryonic signatureC Verdelli, I Forno, V Vaira, et al.European Journal of Endocrinology|September 8, 2016
MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspectsC Verdelli, S CorbettaHistology and Histopathology|May 30, 2020
Intratumor heterogeneity in human parathyroid tumorsC Verdelli, G S Tavanti, S CorbettaDisease Markers|March 9, 2016
Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart DefectsE Passeri, R Rigolini, E Costa, et al.Journal of Endocrinological Investigation|July 2, 2021
Clinical, biochemical and genetic findings in adult patients with chronic hypophosphatasemiaV Guarnieri, F Sileri, R Indirli, et al.Bone|May 8, 2020
Circulating fractures-related microRNAs distinguish primary hyperparathyroidism-related from estrogen withdrawal-related osteoporosis in postmenopausal osteoporotic women: A pilot studyC Verdelli, V Sansoni, S Perego, et al.International Journal of Cancer|January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumorsE Peverelli, E Giardino, D Treppiedi, et al.Endocrine|February 16, 2016
EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasmsE Sanpaolo, M Miroballo, S Corbetta, et al.Endocrine-Related Cancer|November 21, 2009
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissueS Corbetta, V Vaira, V Guarnieri, et al.Pageof 8